Terns Pharmaceuticals Stock Forecast

Stock Price Forecast

The 10 analysts that cover Terns Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $46.49, which forecasts a -12.00% decrease in the stock price over the next year. The lowest target is $7.44 and the highest is $58.

Price Target: $46.49 (-12.00%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$7.44	$46.49	$53	$58
Change	-85.92%	-12.00%	+0.32%	+9.79%

Analyst Ratings

The average analyst rating for Terns Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	1	1
Buy	6	6	6	6	4	5
Hold	2	1	1	1	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	10	10	11	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Rodolfo Angele JP Morgan	JP Morgan	Buy Maintains $44 → $45	Buy	Maintains	$44 → $45	-15.77%	Apr 14, 2026
Srikripa Devarakonda Truist Securities	Truist Securities	Strong Buy → Hold Downgrades $56 → $53	Strong Buy → Hold	Downgrades	$56 → $53	+0.32%	Mar 31, 2026
Etzer Darout Barclays	Barclays	Buy → Hold Downgrades $56 → $53	Buy → Hold	Downgrades	$56 → $53	+0.32%	Mar 30, 2026
Silvan Tuerkcan Citizens	Citizens	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Mar 26, 2026
Ritu Baral TD Cowen	TD Cowen	Strong Buy → Hold Downgrades $53	Strong Buy → Hold	Downgrades	$53	+0.32%	Mar 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.19

from -1.03

EPS Next Year

-1.51

from -1.19

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.00M	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-2.21	-1.67	-1.27	-1.12	-1.03	-1.19	-1.51
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.84	-1.03
Avg	-1.19	-1.51
Low	-1.45	-1.78

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.